155 related articles for article (PubMed ID: 18377388)
1. Concomitant triptan and SSRI or SNRI use: what is the risk for serotonin syndrome?
Evans RW
Headache; 2008 Apr; 48(4):639-40. PubMed ID: 18377388
[No Abstract] [Full Text] [Related]
2. Concomitant triptan and SSRI or SNRI use: a risk for serotonin syndrome.
Sclar DA; Robison LM; Skaer TL
Headache; 2008 Jan; 48(1):126-9. PubMed ID: 18005139
[TBL] [Abstract][Full Text] [Related]
3. Concomitant use of triptan, and SSRI or SNRI after the US Food and Drug Administration alert on serotonin syndrome.
Sclar DA; Robison LM; Castillo LV; Schmidt JM; Bowen KA; Oganov AM; Skaer TL; Kogut SJ
Headache; 2012 Feb; 52(2):198-203. PubMed ID: 22289074
[TBL] [Abstract][Full Text] [Related]
4. Do triptan antimigraine medications interact with SSRI/SNRI antidepressants? What does your decision support system say?
Kogut SJ
J Manag Care Pharm; 2011 Sep; 17(7):547-51. PubMed ID: 21870895
[TBL] [Abstract][Full Text] [Related]
5. Association of Coprescription of Triptan Antimigraine Drugs and Selective Serotonin Reuptake Inhibitor or Selective Norepinephrine Reuptake Inhibitor Antidepressants With Serotonin Syndrome.
Orlova Y; Rizzoli P; Loder E
JAMA Neurol; 2018 May; 75(5):566-572. PubMed ID: 29482205
[TBL] [Abstract][Full Text] [Related]
6. The FDA alert on serotonin syndrome with combined use of SSRIs or SNRIs and Triptans: an analysis of the 29 case reports.
Evans RW
MedGenMed; 2007 Sep; 9(3):48. PubMed ID: 18092054
[TBL] [Abstract][Full Text] [Related]
7. Serotonin syndrome risks when combining SSRI/SNRI drugs and triptans: is the FDA's alert warranted?
Wenzel RG; Tepper S; Korab WE; Freitag F
Ann Pharmacother; 2008 Nov; 42(11):1692-6. PubMed ID: 18957623
[TBL] [Abstract][Full Text] [Related]
8. Careful scrutiny of the evidence for drug-drug interactions in clinical decision support systems is necessary.
Horn JR; Hansten PD
J Manag Care Pharm; 2011 Nov; 17(9):713. PubMed ID: 22050397
[No Abstract] [Full Text] [Related]
9. Serotonin syndrome: SSRIs, SNRIs, triptans, and current clinical practice.
Tepper SJ
Headache; 2012 Feb; 52(2):195-7. PubMed ID: 22221260
[No Abstract] [Full Text] [Related]
10. The serotonin syndrome, triptans, and the potential for drug-drug interactions.
Shapiro RE; Tepper SJ
Headache; 2007 Feb; 47(2):266-9. PubMed ID: 17300366
[TBL] [Abstract][Full Text] [Related]
11. The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American Headache Society position paper.
Evans RW; Tepper SJ; Shapiro RE; Sun-Edelstein C; Tietjen GE
Headache; 2010 Jun; 50(6):1089-99. PubMed ID: 20618823
[TBL] [Abstract][Full Text] [Related]
12. Serotonin syndrome and rhabdomyolysis induced by concomitant use of triptans, fluoxetine and hypericum.
Bonetto N; Santelli L; Battistin L; Cagnin A
Cephalalgia; 2007 Dec; 27(12):1421-3. PubMed ID: 17868285
[No Abstract] [Full Text] [Related]
13. Serotonin toxicity.
Gillman K
Headache; 2008 Apr; 48(4):640-1. PubMed ID: 18377389
[No Abstract] [Full Text] [Related]
14. Onset of Transient Sadness Following the Concomitant Use of a Triptan and Selective Serotonin Reuptake Inhibitor/Serotonin Norepinephrine Reuptake Inhibitors Therapy: A Case Report.
Meng Y; Yuen J
J Pharm Pract; 2023 Jun; 36(3):705-710. PubMed ID: 34962845
[No Abstract] [Full Text] [Related]
15. [Serotonin syndrome].
Yamawaki S; Iwamoto Y
Ryoikibetsu Shokogun Shirizu; 2003; (38):370-3. PubMed ID: 12877005
[No Abstract] [Full Text] [Related]
16. Triptans and serotonin syndrome.
Fine A; Bastings E
Headache; 2012; 52(7):1184-5; author reply 1185-8. PubMed ID: 22755550
[No Abstract] [Full Text] [Related]
17. Triptans and serotonin syndrome.
Evans RW
Cephalalgia; 2008 May; 28(5):573-4; author reply 574-5. PubMed ID: 18355351
[No Abstract] [Full Text] [Related]
18. Triptans, SSRIs/SNRIs and serotonin syndrome.
Rothrock JF
Headache; 2010 Jun; 50(6):1101-2. PubMed ID: 20618824
[No Abstract] [Full Text] [Related]
19. From the editorial office.
Rothrock JF
Headache; 2012; 52(7):1069. PubMed ID: 22755549
[No Abstract] [Full Text] [Related]
20. Incidence of Serotonin Syndrome With Combined Use of Linezolid and Serotonin Reuptake Inhibitors Compared With Linezolid Monotherapy.
Karkow DC; Kauer JF; Ernst EJ
J Clin Psychopharmacol; 2017 Oct; 37(5):518-523. PubMed ID: 28796019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
